Post Market Study Using the Xoft Axxent System

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

March 26, 2007

Primary Completion Date

June 6, 2013

Study Completion Date

May 7, 2016

Conditions
Breast Cancer
Interventions
RADIATION

Electronic brachytherapy (Axxent System)

3.4 Gy per fraction for 10 fractions for a total of 34 Gy.

Trial Locations (10)

10003

Beth Israel Medical Center, New York

10601

Dickstein Cancer Center- White Plains Hospital, White Plains

20910

Holy Cross Medical Center, Silver Spring

30060

Wellstar-Kennestone Cancer Center, Marietta

60612

Rush University Medical Center, Chicago

60805

Little Company of Mary Hospital, Evergreen Park

73104

Oklahoma University Health Science Center, Oklahoma City

94401

Mills Peninsula Hospital, San Mateo

98104

Swedish Cancer Institute, Seattle

02903

Rhode Island Hospital, Providence

All Listed Sponsors
lead

Xoft, Inc.

INDUSTRY

NCT01017549 - Post Market Study Using the Xoft Axxent System | Biotech Hunter | Biotech Hunter